Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210038058 210007227 1.76 91.9 Curative (C) 2017-03-31 2017-09-12 ESPHALL TRIAL Y Y 210012772 TRIAL
210038059 210018952 1.75 91 Curative (C) 2016-08-21 2016-09-27 Temozolomide + RT N null 210012870 TEMOZOLOMIDE + RT
210038060 210018955 1.75 82 Curative (C) 2014-02-10 2014-02-25 Temozolomide + RT N Y 210012887 TEMOZOLOMIDE + RT
210038061 210007295 1.75 null Palliative (P) 2018-02-03 2018-02-07 Trial Unspecified N N 210012963 TRIAL
210038062 210007338 null 54.7 Curative (C) 2017-09-20 2017-09-20 Trial Unspecified N Y 210013032 TRIAL
210038063 210007354 1.65 87.3 Unknown (U) 2015-10-31 2015-11-05 Trial Unspecified 2 N 210013045 TRIAL
210038064 210007360 1.57 48.5 Curative (C) 2018-03-09 2018-08-28 CNS HGG HERBY Bevacizumab Y 0 210013090 TRIAL
210038065 210007371 null 70.8 Curative (C) 2014-11-24 2015-05-27 IBRUTINIB N N 210013093 IBRUTINIB
210038066 210007406 1.61 87.6 Palliative (P) 2019-05-29 2019-11-12 Lomustine 2 N 210013144 LOMUSTINE
210038067 210007418 1.68 96 Curative (C) 2014-07-04 2014-07-08 Rituximab N N 210013173 RITUXIMAB
210038068 210007430 1.76 0 Palliative (P) 2017-01-26 2017-01-26 Lomustine 01 N 210013223 LOMUSTINE
210038069 210007463 null 0 Curative (C) 2016-11-22 2017-09-30 Rituximab N N 210013297 RITUXIMAB
210038070 210007469 1.63 58.3 Palliative (P) 2014-11-01 2016-07-28 Lomustine Y N 210013298 LOMUSTINE
210038072 210007513 1.79 75 Palliative (P) 2014-07-11 2014-08-26 Bendamustine+Rituximab(Sub Courses) N N 210013469 BENDAMUSTINE + RITUXIMAB
210038073 210019042 1.86 82.8 Curative (C) 2017-03-11 2017-04-21 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB null N 210013478 FCR
210038074 210007527 0 77.9 Curative (C) 2015-12-29 2016-02-23 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210013481 FCR
210038075 210007561 1.73 78 Neo-adjuvant (N) 2016-10-03 2016-11-01 FLAIR Trial Y N 210013588 FLAIR TRIAL
210038076 210007592 null 64.8 Palliative (P) null 2019-10-16 FLAIR Trial 01 null 210013640 FLAIR TRIAL
210038077 210019088 1.72 65.1 Curative (C) 2016-12-31 2017-01-01 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210013727 FCR
210038078 210007658 1.67 106.8 Curative (C) 2019-03-12 2019-03-13 Bendamustine+Rituximab(Sub Courses) N N 210013754 BENDAMUSTINE + RITUXIMAB
210038079 210007670 null 61.2 Curative (C) 2013-09-19 2014-03-02 ALL UKALL2003 TRIAL N N 210013789 UKALL 2003
210038080 210007705 1.58 60.7 Curative (C) 2017-05-01 2018-03-02 METHOTREXATE Y N 210013874 METHOTREXATE
210038081 210019118 null 46.1 Curative (C) 2014-09-14 2014-09-14 ALL UKALL2003 B: Ph VII Maintenance null null 210013914 UKALL 2003
210038082 210007748 1.45 55.9 Curative (C) 2016-03-04 2016-03-04 ALL UKALL60+ TRIAL N N 210013944 UKALL60+
210038083 210007765 1.78 62 Curative (C) 2015-11-18 2016-10-14 ALL UKALL60+ TRIAL N N 210013990 UKALL60+
210038084 210007791 1.71 18.3 Curative (C) 2018-11-01 2018-12-02 IDELALISIB + RITUXIMAB 99 N 210014046 IDELALISIB + RITUXIMAB
210038085 210007810 1.57 77.7 Disease modification (D) 2016-01-15 2016-08-26 R Chlorambucil 02 N 210014068 CHLORAMBUCIL + RITUXIMAB
210038086 210007813 0 91.3 Disease modification (D) 2015-11-10 2016-05-31 Imatinib 400mg 01 N 210014072 IMATINIB
210038087 210007881 1.71 77.7 Curative (C) 2018-01-26 2018-09-25 Chlorambucil + Pred + Rituximab Y N 210014253 CHLORAMBUCIL + RITUXIMAB
210038088 210007917 1.73 89.9 Curative (C) 2015-01-02 2015-01-09 IDELALISIB + RITUXIMAB N N 210014311 IDELALISIB + RITUXIMAB
210038089 210007980 1.72 69.8 Curative (C) 2015-08-06 2016-02-19 ALL UKALL2003 TRIAL N N 210014466 UKALL 2003
210038090 210008002 1.83 47.5 Curative (C) 2018-07-08 2018-07-08 CHLORAMBUCIL + OBINUTUZUMAB N N 210014497 CHLORAMBUCIL + OBINUTUZUMAB
210038091 210008045 1.63 57.3 Curative (C) 2019-10-29 2019-10-29 ALL UKALL2003 TRIAL 02 N 210014561 UKALL 2003
210038092 210008063 null 59.5 Palliative (P) 2016-04-03 2016-05-03 CHLORAMBUCIL + OBINUTUZUMAB N N 210014595 CHLORAMBUCIL + OBINUTUZUMAB
210038095 210008137 1.7 66.7 Curative (C) 2014-12-11 2015-06-22 Mercaptopurine N N 210014747 MERCAPTOPURINE
210038096 210008154 1.82 66.7 Curative (C) 2018-05-08 2018-05-08 Venetoclax N N 210014775 VENETOCLAX
210038098 210008318 1.58 83 null 2016-06-16 2016-09-16 Alemtuzumab(INTRAVENOUS) N N 210015206 ALEMTUZUMAB
210038099 210008324 1.82 82 Curative (C) 2017-04-17 2017-04-17 Mercaptopurine N N 210015216 MERCAPTOPURINE
210038100 210008341 1.64 55.9 Curative (C) 2014-11-22 2015-09-15 ALL Int Guide A/B/C Maint Ph V N null 210015224 ALL INTERIM GUIDELINES
210038101 210008384 null null Curative (C) 2017-06-01 2017-06-20 MERCAPTOPURINE + METHOTREXATE 02 N 210015310 MERCAPTOPURINE + METHOTREXATE
210038102 210008535 null null Curative (C) 2018-12-06 2018-12-17 null N N 210015631 CARBOPLATIN
210038103 210008546 null null Curative (C) 2017-06-28 2018-01-28 CHOP R - 21 days Y N 210015677 CHOP R
210038104 210019410 1.71 22.1 Palliative (P) 2018-05-11 2018-05-15 Etoposide Conditioning N null 210015705 ETOPOSIDE
210038105 210008564 1.53 83 Disease modification (D) 2018-02-12 2018-06-25 BLINATUMOMAB N N 210015709 BLINATUMOMAB
210038106 210008616 null 69.3 Curative (C) 2017-06-12 2017-07-11 Etoposide oral null null 210015816 ETOPOSIDE
210038107 210019469 0 35.8 Curative (C) 2015-11-23 2015-11-26 Alemtuzumab cond (RI ALLO CAMP100) N N 210015905 ALEMTUZUMAB
210038108 210019478 1.78 22.5 Disease modification (D) 2017-01-02 2017-07-31 CARBOPLATIN 02 N 210015978 CARBOPLATIN
210038109 210019493 1.74 85 Palliative (P) 2017-04-15 2017-04-24 Etoposide Conditioning N null 210016143 ETOPOSIDE
210038111 210008767 null 17.6 Curative (C) 2017-09-16 2017-11-05 Chlorambucil N N 210016332 CHLORAMBUCIL
210038112 210008923 1.68 null Palliative (P) 2019-03-27 2019-03-27 MERCAPTOPURINE + METHOTREXATE N N 210016939 MERCAPTOPURINE + METHOTREXATE